Overview

A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008)

Status:
Completed
Trial end date:
2003-03-01
Target enrollment:
Participant gender:
Summary
A study to evaluate the effect of kidney disease, from mild to severe disease, on a diabetes medication
Phase:
Phase 1
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Sitagliptin Phosphate